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In a 2002–2004 prospective cohort study of deliveries of infants at <28 weeks at 14 US centers, the authors
sought the antecedents of white matter damage evident in newborn cranial ultrasound scans (ventriculomegaly
and an echolucent lesion) and of cerebral palsy diagnoses at age 2 years. Of the 1,455 infants enrolled, those
whose mothers received an antenatal steroid tended to have lower risks of ventriculomegaly and an echolucent
lesion than their peers (10% vs. 23%, P < 0.001 and 7% vs. 11%, P ¼ 0.06, respectively). Risk of ventriculo-
megaly was increased for infants delivered because of preterm labor (adjusted odds ratio (OR) ¼ 2.3, 95%
confidence interval (CI): 1.1, 4.9), preterm premature rupture of fetal membranes (OR ¼ 3.6, 95% CI: 1.5, 8.7),
and cervical insufficiency (OR ¼ 2.8, 95% CI: 1.4, 5.5) when compared with infants delivered because of pre-
eclampsia. Risk of an echolucent lesion was increased for infants delivered because of preterm labor (OR ¼ 2.7,
95% CI: 1.2, 5.7) and intrauterine growth retardation (OR ¼ 3.3, 95% CI: 1.2, 9.4). The doubling of diparesis risk
associated with preterm labor and with preterm premature rupture of fetal membranes did not achieve statistical
significance, nor did the doubling of quadriparesis risk and the tripling of diparesis risk associated with cervical
insufficiency.
cerebral palsy; cervix uteri; fetal membranes, premature rupture; infant, premature; leukomalacia, periventricular;
obstetric labor, preterm; pre-eclampsia; steroids
Abbreviations: ELGAN, Extremely Low Gestational Age Newborns; pPROM, preterm premature rupture of fetal membranes.
Babies born at extremely low gestational ages (<28
weeks) are at increased risk of neonatal white matter dam-
age and later motor, cognitive, and behavioral impairments
(1). One explanation for the link between extremely low
gestational age and cerebral white matter damage is that
the same disorders that lead to preterm birth can also dam-
age the developing brain (2). With this explanation, the
pregnancy disorder and its correlates are the potential focus
of attention (3–6).
Cranial ultrasound lesions evident when the infant is in
the intensive care nursery predict cerebral palsy diagnoses
years later (7). However, explanations for the link between
white matter damage and cerebral palsy need not invoke any
pregnancy or prenatal characteristic. Rather, they view
lesions indicative of white matter damage as the earliest
expression of the very disorder that will become clinically
evident years later as movement dysfunctions (8, 9). Ven-
triculomegaly and an echolucent lesion are considered in-
dicators for different aspects of white matter damage, with
ventriculomegaly a marker of diffuse and echolucent lesion
a marker of focal white matter damage (10).
Our large sample of infants born before the 28th week
enabled us to assess how well pregnancy disorders and their
clinical correlates predict early postnatal cerebral white
matter damage and the later cerebral palsy diagnoses of
quadriparesis, diparesis, and hemiparesis. Because these
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3 cerebral palsy diagnoses differ in their correlates (11, 12),




The Extremely Low Gestational Age Newborns (ELGAN)
study was designed to identify characteristics and expo-
sures that increase the risk of structural and functional
neurologic disorders in extremely low gestational age new-
borns. During 2002–2004, women delivering before 28
weeks of gestation at one of 14 participating institutions
in 11 cities in 5 US states were asked to enroll in the study.
At each site, the enrollment and consent processes were
approved by the local institutional review board. Partici-
pating centers and ELGAN study investigators are listed in
the Appendix.
Mothers were approached for consent either upon ante-
natal admission or shortly after delivery, depending on the
clinical circumstance and institutional preference. A total of
1,249 mothers of 1,506 infants consented. Infants with birth
defects and/or aneuploidy were excluded. Approximately
260 women were either missed or did not consent to
participate.
Protocol scans
Technicians at all of the hospitals performed routine scans
using high-frequency transducers (7.5 MHz and 10 MHz).
Ultrasound studies always included the 6 standard quasi-
coronal views and 5 sagittal views, using the anterior fon-
tanel as the sonographic window (13). The first of 3 sets of
protocol scans was obtained between the first and fourth
days (n ¼ 1,123). The second protocol scans were obtained
between the fifth and 14th days (n ¼ 1,302), and the third
protocol scans were obtained between the 15th day and the
40th week (n ¼ 1,268). Of the 1,506 infants enrolled, 61
(4%) failed to have at least one of the protocol scans. We
therefore had a final sample of 1,455 infants for this analysis
(Figure 1).
Reading procedures
All ultrasound scans were read independently by 2 read-
ers who were unaware of clinical information. When the
2 readers differed in their recognition of a lesion, the films
were sent to a third (tie-breaking) reader who was unaware
of the opinions of the first 2 readers. Details about the pro-
cedure and efforts to minimize observer variability are pre-
sented elsewhere (14).
Demographic and pregnancy variables
After delivery, a trained research nurse interviewed each
mother in her native language using a structured question-
naire and following protocols detailed in the study manual.
The mother’s report of her own characteristics and expo-
sures, as well as the sequence of events leading to preterm
delivery, were preferentially weighted over those in her
medical record. The only exception occurred when the
mother’s recollection of her last menstrual period was un-
certain (discussed below). The research nurse reviewed the
mother’s chart using a second structured data collection
form. We relied on the medical record for events following
admission.
The clinical circumstances that led to each maternal ad-
mission and ultimately to each preterm delivery were oper-
ationally defined by using both data from the maternal
interview and data abstracted from the medical record
(15). Preterm labor was defined as progressive cervical di-
lation with regular contractions and intact membranes. Pre-
term premature rupture of fetal membranes (pPROM) was
defined as the presence of vaginal pooling with either docu-
mented nitrazine-positive testing or ferning prior to regular
uterine activity. Preeclampsia was defined as new-onset hy-
pertension and proteinuria of sufficient severity to warrant
delivery for either a maternal or fetal indication. For a di-
agnosis of cervical insufficiency, a woman had to present
with cervical dilation of more than 2 cm in the absence of
membrane rupture and detected or perceived uterine activ-
ity. Placental abruption was defined as presentation with
a significant amount of vaginal bleeding (documented either
in the medical record or by a postpartum hematocrit of
<24%) and a clinical diagnosis of placental abruption in
Figure 1. Description of the sample of children analyzed regarding maternal antenatal complications and risk of neonatal cerebral white matter
damage and later cerebral palsy (CP), United States, 2002–2004.
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the absence of cervical change. Presentations included
under the category of fetal indication/intrauterine growth
retardation included nonreassuring fetal testing, oligo-
hydramnious, Doppler abnormalities of umbilical cord
blood flow, or severe intrauterine growth retardation based
on antepartum ultrasound examination. For the purposes of
this study, the initial complication that caused presentation
to medical attention was the focus of analysis.
The gestational age estimates were based on a hierarchy
of the quality of information available. Most desirable
were estimates based on the dates of embryo retrieval or
intrauterine insemination or ultrasound before the 14th
week of gestation (62%). When these measures were not
available, we relied sequentially on an ultrasound at
14 weeks or more (29%), last menstrual period without
ultrasound confirmation (7%), and gestational age re-
corded in the log of the neonatal intensive care unit
(1%). The birth weight z score is the number of standard
deviations the infant’s birth weight is above or below the
median weight of infants at the same gestational age in
a standard data set. We chose the standard offered by
Yudkin et al. (16).
24-Month neurologic examination
Families were invited to bring their child for a develop-
mental assessment close to the time when he or she would be
24-months corrected gestational age. A total of 1,056 (88%
of the eligible 1,198) children had a neurologic examination
then (Figure 1). Of these children, 77% were assessed within
the range of 23.5–27.9 months.
The neurologic evaluation was performed by examiners
using a structured data collection form. Procedures to stan-
dardize the neurologic examination and minimize examiner
variability are presented elsewhere (17). The topographic
diagnosis of cerebral palsy (quadriparesis, diparesis, or
hemiparesis) was based on an algorithm that used these
data (12).
Data analysis
The newborn, rather than the mother, was the focus of
these analyses. Women who delivered multiple gestations
are therefore represented multiple times. We included mul-
tiple gestations with singletons after we documented a lack
of cerebral palsy concordance among twins and triplets.
Multifetal gestations did not have a higher risk of any cere-
bral palsy diagnosis. In addition, only 3 of 112 complete sets
of twins were concordant for having a cerebral palsy diag-
nosis, whereas 2 would be expected by chance.
For descriptive Tables 1 and 2, we used the standard
epidemiologic approach in cohort analysis. We compared
the frequency of each ultrasound lesion and each cerebral
palsy diagnosis among infants in strata defined by the char-
acteristics and exposures of their mother, pregnancy, and
delivery.
Ultrasound characteristics of the brain tended to occur
together in our sample. Therefore, we compared infants
who had each lesion with the 975 infants whose scans
showed no abnormality.
The generalized form of the null hypothesis is that the
occurrence of each brain ultrasound image and cerebral palsy
diagnosis does not vary with each maternal/pregnancy/
delivery characteristic or exposure.
The multivariable analyses focused on the contribution
of the pregnancy disorder that preceded preterm delivery.
We adjusted for gestational age and receipt of any ante-
natal steroids. In all analyses, the referent group consisted
of infants delivered because of preeclampsia, the sub-
group with the lowest prevalence of ventriculomegaly
and echolucent lesion in our cohort. Because differences
in population characteristics and obstetric management
are likely to exist between institutions within our net-
work, we accounted for potential nonindependence of
babies within different institutions by using conditional
logistic regression that specifies a term for each delivering
center.
In early sets of analyses, we adjusted for gestational age
in 2 ways, by both week of gestation (23, 24, 25, 26, 27) and
groups of weeks (23–24, 25–26, 27). Because the results
were almost identical, we present only those with the
groups-of-weeks adjustment in this paper.
RESULTS
Pregnancy and antenatal management characteristics
Delivery and antenatal management characteristics are
given in Table 1. The risk of white matter damage or a ce-
rebral palsy diagnosis did not differ with the administra-
tion of maternal antenatal antibiotics. Infants whose
mothers did not receive an antenatal corticosteroid had
an increased rate of cerebral white matter damage com-
pared with those exposed to an antenatal steroid. Incom-
plete and complete courses appeared to be equally
protective against cranial ultrasound lesions, although they
seemed to have a minimal effect on the occurrence of
a cerebral palsy diagnosis.
The risk of ventriculomegaly was lowest for neonates
delivered of pregnancies complicated by preeclampsia,
whereas the risk of echolucent lesion was lowest in preg-
nancies complicated by both preeclampsia and placental
abruption. Cranial ultrasound lesions were most prevalent
among infants delivered of pregnancies complicated by pre-
term labor or cervical insufficiency. The risk of a cerebral
palsy diagnosis was highest in pregnancies complicated by
cervical insufficiency.
Compared with babies not exposed to labor, those who
experienced labor were at increased risk of both ventricu-
lomegaly and echolucent lesion, as well as all 3 cerebral
palsy diagnoses. Vaginal delivery was associated with
a significantly increased frequency of a cranial ultrasound
lesion and an increased frequency of 2 of the 3 forms of
cerebral palsy (diparesis and hemiparesis). Multiple gesta-
tions were not at increased risk of either ultrasound lesion
or any cerebral palsy diagnosis. A total of 248 infants in the
ultrasound sample and 192 in the cerebral palsy sample
were delivered more than 72 hours after membrane rup-
ture. They were not at a higher risk of a cranial ultrasound
lesion or a cerebral palsy diagnosis than infants born after
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a shorter latency interval between membrane rupture and
delivery.
Magnesium sulfate was administered as a seizure prophy-
lactic or a tocolytic to a subset of this population. Infants
exposed for the indication of maternal tocolysis were not at
reduced risk of a cranial ultrasound lesion and were at a min-
imally reduced risk of quadriparesis and diparesis. Among
those exposed to magnesium for seizure prophylaxis, how-
ever, the risk of ventriculomegaly was reduced, but the risks
of a cerebral palsy diagnosis were not.
Table 1. Risk of Cranial Ultrasound Lesions and Cerebral Palsy Diagnoses in Relation to Delivery Characteristics
(Row Percentages), United States, 20022004
Delivery
Characteristic




No. Quadriparesis Diparesis Hemiparesis No.
Maternal antibiotics
Yes 11 7 426 9 4 1 313
No 12 8 950 5 3 2 712
Antenatal steroid
Complete 10 8 906 6 4 2 681
Partial 12 6 385 4 3 3 260
Any 10* 7 1,296 6 3 2 943
None 23 11 159 8 4 0 113
Pregnancy complication
Preterm labor 14** 10** 642 6 4 3 474
pPROM 11 7 307 6 4 2 231
Preeclampsia 5 4 197 5 1 1 139
Abruption 9 2 152 3 3 2 114
Cervical insufficiency 16 9 87 15 5 0 55
Fetal indication 10 11 70 9 2 0 43
Duration of labor, hours
0 7** 4** 375 4 2 0.4** 256
>0 to 12 14 10 334 5 2 1 233
>12 13 8 746 7 5 3 567
Duration of membrane
rupture, hours
<1 12 8 863 6 3 1 616
1 to 24 13 10 240 9 4 4 170
>24 to 72 14 7 104 4 3 5 78
>72 10 6 248 6 4 1 192
Magnesium
Tocolysis 12*** 8 781 5 3 2 571
Seizure prophylaxis 5 4 182 5 3 1 135
None 14 9 480 8 5 1 341
Vaginal delivery
Yes 15** 11* 511 7 6 3** 354
No 10 6 944 6 2 1 702
Type of gestation
Singleton 12 8 987 6 4 2 700
Multiple 12 7 468 7 3 2 356
Row percentage 12 8 6 4 2
Maximum no. of infants 172 113 1,455 64 37 19 1,056
Abbreviation: pPROM, preterm premature rupture of fetal membranes.
* P  0.001; **P  0.01; ***P  0.05; all values were obtained by Pearson’s v2 or Fisher’s exact test.
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Neonatal and gestational age characteristics
Neonatal and gestational age characteristics are shown in
Table 2. Compared with males, female infants had a lower
risk of both ventriculomegaly and hemiparesis. As gesta-
tional age advanced, the risk of both ultrasound lesions
and a later cerebral palsy diagnosis declined, especially
the risks of both ventriculomegaly and hemiparesis. Unlike
the trends seen with gestational age, no trends were found
with birth weights or birth weight z scores.
Multivariable analyses
We created conditional logistic regression models that
compared each of the pregnancy complications with pre-
eclampsia and adjusted for gestational age and receipt of
an antenatal steroid. These models also enabled us to ac-
count for the potential nonindependence of babies within
each hospital (Table 3). Preterm labor, pPROM, and cervical
insufficiency were associated with a more than doubling of
the risk of ventriculomegaly, whereas delivery because of
preterm labor was associated with a more than doubling
of the risk of echolucent lesion.
Children born following preterm labor and pPROM were
at twice the risk of diplegia as infants delivered because of
a maternal indication (Table 4). Cervical insufficiency was
associated with a doubling of quadriplegia risk and a tripling
of diplegia risk. However, none of the pregnancy disorders
was a statistically significant predictor of quadriparesis, di-
paresis, or hemiparesis. Results of a multinomial model of
cerebral palsy diagnosis were similar to those obtained with
3 individual conditional logistic regression models, each
comparing children who had a specific cerebral palsy
Table 2. Risk of Cranial Ultrasound Lesions and Cerebral Palsy Diagnoses in Relation to Neonatal and Gestational
Age Characteristics (Row Percentages), United States, 20022004
Infant Characteristic




No. Quadriparesis Diparesis Hemiparesis No.
Sex
Female 10*** 7 681 5 3 1*** 505
Male 14 9 774 7 4 3 551
Gestational age, weeks
23 21* 11 109 15 8 4* 48
24 17 10 268 12 8 2 164
25 12 8 296 6 2 2 214
26 12 8 349 4 2 2 273
27 6 5 433 3 3 1 357
Birth weight, g
750 14 8 621 9 5 3 385
751 to 1,000 10 7 579 4 2 2 467
1,001 11 7 232 5 4 1 184
>1,250 13 17 23 15 0 0 20
Birth weight z scorea
<2 8 4 104 2 0 5** 56
<1 10 5 206 6 3 1 142
1 to 1 12 8 992 6 4 2 736
>1 13 10 131 7 5 1 102
>2 18 18 22 20 0 0 20
Birth head circumference
z scorea
<2 8 4 134 5 0 4 82
<1 10 7 308 6 5 1 235
1 to 1 13 8 757 6 4 2 550
>1 14 10 162 9 3 2 118
>2 16 9 43 11 0 3 35
Row percentage 12 8 6 4 2
Maximum no. of infants 172 113 1,455 64 37 19 1,056
* P  0.001; **P  0.01; ***P  0.05; all values were obtained by Pearson’s v2 or Fisher’s exact test.
a Yudkin et al. (16) standard.
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diagnosis with children not given any cerebral palsy diag-
nosis (data not shown).
DISCUSSION
Overview
To our knowledge, this study is the largest to date of the
relation between antenatal characteristics and the risks of
cerebral white matter damage and later diagnosis of cerebral
palsy among children born before the 28th week of gesta-
tion. Our major findings are discussed below.
The risk of ventriculomegaly was elevated for infants
whose mothers presented with preterm labor, prelabor, pre-
mature rupture of membranes, or cervical insufficiency,
whereas the risk of an echolucent lesion was elevated for
infants born to women who presented with preterm labor.
The lowest gestational age infants had the highest risk of
ultrasound-defined cerebral white matter damage and of all
3 cerebral palsy diagnoses. A partial course of antenatal
corticosteroids was as protective as a full course against
white matter damage. Compared with singletons, twins
and triplets were not at higher risk of white matter damage.
The lowest risk of a cerebral palsy diagnosis was found for
children born to women who presented with preeclampsia.
Antenatal corticosteroids did not reduce the risk of a cerebral
palsy diagnosis. The higher risks of a cerebral palsy diag-
nosis associated with other disorders leading to delivery
before the 28th week of gestation did not reach statistical
significance.
Relation between white matter damage and cerebral
palsy diagnoses
In our sample, ultrasound lesions indicative of white mat-
ter damage predict cerebral palsy diagnoses (7). We chose to
study ultrasound-defined brain lesions because they are the
indicator of brain damage outcomes more ‘‘proximal’’ to
antenatal events than the more ‘‘distal’’ diagnoses of cere-
bral palsy, which might be influenced by occurrences, ex-
posures, and interventions in the neonatal intensive care unit
and in early childhood. Thus, associations between antena-
tal characteristics and cerebral neonatal cranial ultrasound
lesions can be expected to be stronger than associations
between antenatal characteristics and a later cerebral palsy
diagnosis, which was in fact what we observed.
Table 3. Risk Ratios (Point Estimates and 95% Confidence Intervals) for Each Cranial Ultrasound Lesion
Associated With 6 Pregnancy Disorders, United States, 20022004a
Pregnancy Complication
Ultrasound Lesion
Ventriculomegaly Echolucent Lesion Either
RR 95% CI RR 95% CI RR 95% CI
Preterm labor 2.6 1.3, 5.1 2.5 1.2, 5.4 2.5 1.4, 4.5
pPROM 2.2 1.04, 4.5 1.6 0.7, 3.7 2.2 1.2, 4.0
Abruption 1.4 0.6, 3.3 0.4 0.1, 1.6 1.0 0.5, 2.3
Cervical insufficiency 3.0 1.2, 7.2 2.3 0.8, 6.6 2.5 1.1, 5.4
Fetal indication 1.8 0.7, 5.1 2.7 0.9, 7.7 2.6 1.1, 5.8
Preeclampsia 1.0 1.0 1.0
Abbreviations: CI, confidence interval; pPROM, preterm premature rupture of membranes; RR, risk ratio.
a Conditional logistic regression was used to account for potential nonindependence of babies born in the same
hospital while allowing adjustment for gestational age and for receipt of any antenatal steroid.
Table 4. Risk Ratios (Point Estimates and 95% Confidence Intervals) for Each Cerebral Palsy Diagnosis
Associated With 6 Pregnancy Disorders, United States, 20022004
Pregnancy Complication
Cerebral Palsy Diagnosis
Quadriparesis Diparesis Hemiparesis Any Cerebral Palsy
RR 95% CI RR 95% CI RR 95% CI RR 95% CI
Preterm labor 1.0 0.4, 4.4 2.1 0.5, 9.4 3.2 0.4, 25 1.4 0.7, 2.9
pPROM 0.9 0.4, 2.4 2.2 0.5, 11 2.2 0.2, 20 1.3 0.6, 2.9
Abruption 0.3 0.1, 1.4 1.2 0.2, 8.0 2.2 0.2, 26 0.7 0.2, 1.8
Cervical insufficiency 2.4 0.8, 7.4 3.4 0.5, 23 —b 2.4 0.9, 6.4
Fetal indication 2.0 0.5, 7.4 2.1 0.2, 24 —b 1.8 0.6, 5.9
Preeclampsia 1.0 1.0 1.0 1.0
Abbreviations: CI, confidence interval; pPROM, preterm premature rupture of membranes; RR, risk ratio.
a Conditional logistic regression was used to account for potential nonindependence of babies born in the same
hospital while allowing adjustment for gestational age and for receipt of any antenatal steroid.
b Nochildwithhemiparesiswasdeliveredbecauseofcervical insufficiencyora fetal indication,so therewerezerocells.
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We expected to find that the pregnancy and delivery ante-
cedents of cerebral white matter damage were the antece-
dents of cerebral palsy diagnoses. We did see some
similarities, but the power of this study precluded our iden-
tifying with confidence associations between pregnancy and
delivery characteristics and the risk of cerebral palsy
diagnoses.
Disorders that lead to preterm delivery
Infants delivered preterm because of the indication of pre-
eclampsia have been reported to be at reduced risk of white
matter damage (18, 19) and cerebral palsy (20–22). We, too,
observed that infants born to preeclamptic women were at
reduced risk of a cranial ultrasound abnormality and of a ce-
rebral palsy diagnosis. One explanation for this apparent pro-
tection is that preeclampsia tends not to be characterized by
intrauterine inflammation (15). Fetal indication/intrauterine
growth retardation also tends not to be associated with intra-
uterine inflammation (15), but infants delivered because of
these indications are not at such a reduced risk of white matter
damage. We are not sure why this should be, but the possi-
bility exists that preeclampsia is characterized by production
of maturation-promoting or neuroprotective substances (23)
but that intrauterine growth retardation unaccompanied by
preeclampsia is not.
Preterm labor, frequently accompanied by indicators and
correlates of inflammation (24–26), is often, but not invari-
ably (27), associated with an increased risk of neonatal
cranial ultrasound lesions. Consistent with this observation,
we found that infants born to women who presented with
preterm labor were at increased risk of ventriculomegaly
and echolucent lesion and of a statistically insignificant
doubling of the risk of diparetic cerebral palsy and a tripling
of the risk of hemiparetic cerebral palsy.
Consistent with another report (28), we also found that
infants whose mothers had cervical insufficiency were at
increased risk of ventriculomegaly and echolucent lesion.
We also observed an apparent, but statistically insignificant
doubling of quadriparetic cerebral palsy risk and a tripling
of diplegic cerebral palsy risk. Observations that intrauter-
ine infection can accompany cervical insufficiency (29, 30)
lead to the possibility that the cervical insufficiency associ-
ations with brain damage reflects the influences of circulat-
ing products of inflammation (31).
Corticosteroids
The utility of antenatal corticosteroids in reducing cranial
ultrasound lesions has been well documented (32) and
incorporated into contemporary perinatal practice (33).
Clinical practice has been to allow 48 hours to elapse be-
tween the initial dose and the assumption of maximal fetal
maturation. However, this interval has been based on obser-
vations of pulmonary and not central nervous system mat-
uration. Our observations suggest that the brain protection
benefit is achieved before 48 hours.
Unlike recent investigators (22), we did not observe an-
tenatal corticosteroid-associated reductions in the risk of the
cerebral palsy diagnoses. Our results, however, are similar
to those of another group of investigators, who noted a re-
duced frequency of white matter disease after antenatal ste-
roid exposure but did not observe a reduction in the
occurrence of cerebral palsy (34).
Magnesium
Infants exposed in utero to magnesium prescribed for
maternal seizure prophylaxis were at reduced risk of white
matter damage, whereas infants exposed to magnesium given
as a tocolytic were not. These findings support the impression
that magnesium does not reduce the risk of any form of sono-
graphically defined brain damage (35). These observations
also suggest that the indication (preeclampsia) and not the
therapy/prophylaxis (magnesium) is most closely associated
with reduced risk of cerebral white matter damage.
Randomized clinical trials of magnesium given to women
in labor have shown a reduced occurrence of cerebral palsy
in the offspring (36, 37). We found that maternal receipt of
magnesium for tocolysis was associated with a small reduc-
tion in the risk of quadriparetic and diparetic cerebral palsy.
Because ours was an observational study, which might suf-
fer from confounding by indication, we are reluctant to offer
our findings as support equivalent to that found with
randomized clinical trials.
Duration of membrane rupture
Clinically apparent intrauterine inflammation appears to
increase the risk of brain damage and neurodevelopmental
disability (38–40). Since pPROM has been associated with
inflammatory phenomena (24), one would expect, as some
have observed (22, 41), that infants born after pPROM are at
increased risk of white matter damage and a later cerebral
palsy diagnosis. We found a statistically significantly in-
creased risk of ventriculomegaly but not of echolucent le-
sion. We also found nonsignificantly increased risks of
diparesis and hemiparesis.
Some studies support the hypothesis that the longer the
interval between membrane rupture and delivery, the greater
the likelihood of intrauterine infection/inflammation and
clinical chorioamnionitis (42, 43); another study does not
(44). We confirmed previous reports (45–48) that the risk of
cranial ultrasound lesions is unrelated to the latency interval
between membrane rupture and delivery. Additionally, pro-
longed latency was not associated with an increased risk of
any cerebral palsy diagnosis.
Our results are consistent with the possibility that patients
with pPROM can be managed to maximize latency without
increasing the potential for white matter damage or cerebral
palsy. Nevertheless, we urge caution in acting on our find-
ings. Infants of pregnancies most susceptible to clinical
chorioamnionitis following membrane rupture are poten-
tially removed very early in the latency interval from the
pool of infants at risk of brain damage following prolonged
membrane rupture. Thus, our inference of no brain adver-
sities following prolonged membrane rupture might reflect
informative censoring.
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Methodological issues
Although some might view cerebral palsy as a homoge-
neous entity, we do not (11, 12, 49). In this sample, each of
the clinically defined cerebral palsy diagnoses (quadriparesis,
diparesis, and hemiparesis) differs considerably from the
others in severity of impairment, frequency of comorbid
conditions, and risk profile. Thus, although our combining
all of the cerebral palsy diagnoses under one umbrella to
achieve an outcome frequency of 12% is attractive for
achieving power, it is not attractive for achieving homogene-
ity. Nevertheless, for those who prefer to view cerebral palsy
as a single entity, we have included a column in Table 4 for
‘‘any cerebral palsy.’’
Twins born at term appear to be at increased risk of ce-
rebral palsy (50). In our study, however, compared with their
singleton peers, twins and triplets did not have a higher risk
of a cerebral palsy diagnosis, and we found little evidence of
cerebral palsy concordance among the multiple gestations.
Consequently, nonindependence among the multiples is un-
likely to have altered our findings.
Our study has several major strengths, including a large
number of infants delivered at extremely low gestational
ages. These infants are at the highest risk of cranial ultra-
sound abnormalities and cerebral palsy. Prospective in
design, our study enrolled mothers and infants before ascer-
tainment of any outcome, and we collected high-quality
data in a uniform manner. We standardized interviews of
the mothers, minimized observer variability in ultrasound
scan interpretation (14) as well as in assessment of the neu-
rologic examinations (17), and standardized cerebral palsy
diagnoses with a diagnostic and classification algorithm
(12).
Perhaps the main limitation of this study is its low power
for cerebral palsy. We designed our study to have power to
discern a doubling of the risk of an echolucency from 8% to
16% associated with an exposure that occurred in a quarter
of the sample. Each of the later cerebral palsy diagnoses,
however, occurred less frequently than 8% of the time (e.g.,
quadriparesis: 6%; diparesis: 4%; hemiparesis: 2%). Also
contributing to the low power was the low frequency of
some of the more important exposures. For example, cervi-
cal insufficiency, which was associated with a doubling of
quadriparetic cerebral palsy risk and a tripling of diparetic
cerebral palsy risk, occurred in less than 5% (n ¼ 47) of
mothers. Consequently, our study was underpowered to
identify with statistical significance any of the associations
between a pregnancy disorder and a cerebral palsy diagnosis.
Additionally, because unmeasured variables might have
contributed to our findings, we recommend caution when
interpreting these findings.
In summary, in this sample of infants born more than 12
weeks before term, some pregnancy disorders were associ-
ated with increased risks of ultrasound-defined cerebral
white matter damage. Most of these disorders are them-
selves associated with inflammation, raising the possibility
that their association with brain damage reflects inflamma-
tory influences. The increased risks of cerebral palsy diag-
noses for children born to women who presented with these
inflammation-associated disorders did not achieve statistical
significance. The very low risks of cerebral white matter
damage and cerebral palsy diagnoses for the offspring of
women who presented with preeclampsia were lower than
those for children delivered because of fetal indications.
This finding raises the possibility that preeclampsia is
potentially brain protective.
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APPENDIX
Participating Centers (Site Principal Investigator,
Pathologist, Perinatologist)
Baystate Medical Center, Springfield, Massachusetts
(Bhavesh Shah, Solveg Pflueger, Glenn Markenson)
Beth Israel Deaconess Medical Center, Boston, Massa-
chusetts (Camilia R. Martin, Jonathon L. Hecht, Bruce
Cohen)
Brigham and Women’s Hospital, Boston, Massachusetts
(Linda J. Van Marter, Harvey Kliman,* Thomas F. McElrath)
Children’s Hospital, Boston, Massachusetts (Alan Leviton,
Site Principal Investigator)
Massachusetts General Hospital, Boston, Massachusetts
(Robert Insoft, Drucilla Roberts, Laura Riley)
Tufts New England Medical Center, Boston, Massachu-
setts (Cynthia Cole/John Fiascone, Ina Bhan, Sabrina
Craigo/Theresa Marino)
UMass Memorial Medical Center, Worcester, Massachu-
setts (Francis Bednarek, Gamze Ayata, Ellen Delpapa)
Yale-New Haven Hospital, New Haven, Connecticut
(Richard Ehrenkranz, Miguel Reyes-Múgica/Eduardo
Zambrano, Keith P. Williams)
Forsyth Hospital, Baptist Medical Center, Winston-
Salem, North Carolina (T. Michael O’Shea, Dennis W. Ross,
Maggie Harper)
University Health Systems of Eastern Carolina, Green-
ville, North Carolina (Stephen Engelke, John Christie,
Hamid Hadi)
North Carolina Children’s Hospital, Chapel Hill, North
Carolina (Carl Bose, Chad Livasy, Kim Boggess)
DeVos Children’s Hospital, Grand Rapids, Michigan
(Mariel Portenga, Barbara Doss, Curtis Cook)
Sparrow Hospital, Lansing, Michigan (Padmani Karna,
Gabriel Chamyan, Steve Roth)
University of Chicago Hospital, Chicago, Illinois (Michael
D. Schreiber, Aliya Husain, Mahmoud Ismail)
William Beaumont Hospital, Royal Oak, Michigan (Daniel
Batton, Chung-Ho Chang, Robert Lorenz)
* Dr. Kliman, who reviewed the Brigham and Women’s
Hospital slides, is an Obstetrics Department faculty member
at Yale-New Haven Hospital, New Haven, Connecticut.
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